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rom a biological standpoint, the best material for reconstruction of bone defects is the autogenous bone graft. However, as
tissue healing is affected under diabetic conditions, major changes might take place in the revascularization, incorporation,
replacement and remodeling phases of the grafted area. The purpose of this study was to assess the bone healing process in
surgical wounds prepared in tibiae of diabetic rats and filled with autogenous bone. Forty male rats (Rattus norvegicus
albinus, Wistar) were randomly assigned to receive an endovenous injection (penile vein) of either citrate buffer solution
(Group 1 - control; n=20) or streptozotocin dissolved in citrate buffer solution (35 mg/kg) to induce diabetes (Group 2 - diabetic;
n=20). After determination of glycemia, the animals were anesthetized and the anterolateral regions of the tibiae of both limbs
were shaved, antisepsis was performed and longitudinal incisions were made in each limb. The tibiae were exposed and two 2-
mm-diameter surgical cavities were prepared: one in the right limb, filled with particulate autogenous bone and the other in the
left limb, filled with blood clot. The animals were euthanized at 10 and 30 postoperative days. The anatomic pieces were
obtained, submitted to laboratory processing and sections were stained by hematoxylin and eosin and Masson’s Trichrome
for histomorphologic and histometric analyses. In both groups, the wounds filled with autogenous bone graft showed better
results than those filled with blood clot. The control group showed higher new bone formation in wounds filled with autogenous
bone graft at 30 days than the diabetic group, but without statistical significance. It may be concluded that, in general, the new
bone formation occurred with autogenous graft was quantitatively similar between control and diabetic groups and qualitatively
better in the control group.
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INTRODUCTION
The loss of bone tissue from the alveolar ridge, as a
cause of pathologies, periodontitis or invasive surgical
procedures, may cause structural, functional and esthetic
impairments to the dental arch, generating mechanical
problems and hindering the installation of prostheses and
implants. In an attempt to improve the repair process or
even to recover the alveolar anatomy, graft materials and
bone substitutes have been used to fill these defects.
Autogenous bone graft has become the material with
the highest biological acceptance and tissue compatibility,
presenting minimal inflammatory response. However, the
clinical success of bone grafts depends on inflammatory
events that are controlled by regulatory mechanisms,
represented by hormones (insulin, glucocorticoids) and
specific tissue factors. Any alteration in those mechanisms,
particularly diabetes mellitus, an endocrine alteration, may
induce unfavorable reactions in the normal inflammatory
process, possibly causing great changes in the
revascularization, incorporation, substitution and
remodeling grafts stages
The aim of this study was to evaluate the bone repair
process in surgical defects prepared in the tibiae of non-
compensated diabetic rats and filled with autogenous bone
and blood clot.
MATERIAL AND METHODS
Forty male rats (Rattus Norvegicus albinus, Wistar) were
randomly assigned to receive an endovenous injection in
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the penile vein of either citrate buffer solution 0.01 M, pH
4.5 (Group 1 - control; n=20) or streptozotocin (Sigma-
Aldrich Corp., St. Louis, MO, USA) dissolved in citrate buffer
solution at 35 mg/kg body weight for experimental induction
of diabetes (Group 2 - diabetic; n=20). Five days after
induction of diabetes, blood samples were collected from
each animal to determine the glycemic levels using an
automatic blood glucose monitoring system (Accu-Check®;
Roche-Diagnostics Corporation, Indianapolis, IN, USA).
Seven days after confirmation of hyperglycemia (glycemia
>350 mg/dL), the animals were sedated and the anterolateral
regions of the tibiae of both posterior limbs were shaved,
antisepsis was performed and a longitudinal incision was
made in each limb. The tibiae were exposed and two 2-mm-
diameter surgical defects were prepared with trephine burs,
one in each limb. The defect in the right posterior limb was
filled with autogenous particulate bone collected from both
surgical defects, whereas the defect in the left posterior
limb was filled with blood clot. The animals were euthanized
at 10 and 30 postoperative days and the pieces were
submitted to routine laboratorial processing and stained
with hematoxylin and eosin and Masson’s Trichrome for
histomorphometric and histologic analyses. The histologic
analysis was performed by inflammatory cell count and the
histomorphometric analysis was performed with the aid of
“Imagelab 2000” image-analysis software. The results were
analyzed statistically by Kruskal-Wallis test according to
normal curve adherence. Significance level was set at 5%.
RESULTS
Histologic Results
10 days
Group I (Control)
Defect filled with blood clot (CC10): immature bone
trabeculae were observed with wide intratrabecular spaces
filled with connective tissue with collagen fiber bundles
maintaining their organization, large number of fibroblasts
and moderate number of inflammatory cells, mainly
lymphocytes and macrophages.
Defect filled with Graft (CG10): immature bone trabeculae
were observed with wide intratrabecular spaces. Inside the
surgical defects there were bone tissue fragments
corresponding to the grafts. Close to the newly formed bone
tissue margins and the graft fragments, there were numerous
osteoblasts characterizing areas with intense bone
apposition (Figure 1).
Group II (Diabetic)
Defect filled with blood clot (DC10): although the bone
trabeculae were more numerous, they were visibly thinner
compared to those of the control group. Intratrabecular
spaces were wide, with well vascularized connective tissue,
showing few collagen fiber bundles without organization,
several fibroblasts and moderated number of inflammatory
cells.
Defect filled with graft (DG10): similarly to the control
group, it was possible to observe immature bone trabeculae
also presenting wide intratrabecular spaces. There were bone
tissue fragments corresponding to the grafts inside the
surgical defect. Part of those fragments was devitalized,
which was noted by the absence of osteocytes inside the
mineralized material. Osteoblasts around the newly formed
bone and the graft fragments demonstrated new bone
formation activity, though less organized than in the control
group (Figure 2).
30 days
Group I (Control)
Defect filled with blood clot (CC30): The surgical site in
all specimens was repaired by well developed bone tissue.
There was a greater amount of newly formed bone tissue
close to the surgical wound margins, decreasing as it got
closer to the central area of the defect (Figure 3).
Defect filled with graft (CG30): It was observed the total
closing of the defect by well developed bone. The repaired
cortical bone thickness was larger than in the control group
filled with blood clot, which is due to the incorporation of
bone grafts in the area (Figure 4). There were few
intratrabecular spaces, which were filled with collagen fibers,
several osteoblasts and few inflammatory cells.
Group II (Diabetic)
Defect filled with blood clot (DC30): The surgical site
was totally repaired by newly formed bone. However, the
thickness of the repaired cortical decreased as closer it got
from the defect central area, being even thinner than its
respective control group. The newly formed bone was thicker
at the wound margins, becoming thinner than the respective
control group as closer it got to the central area. The bone
lamellae were also more disorganized and there were a large
number of wide intratrabecular spaces, with several
osteoblasts, blood vessels and inflammatory cells (Figure
5).
Defect filled with Graft (DG30): It was observed the total
closing of the defect by well formed bone. However, the
bone layer was thinner than in the corresponding control
group. Bone grafts were incorporated to the newly formed
bone by thin bone trabeculae, with wide intratrabecular
spaces, several collagen fibers in organization, numerous
osteoblasts, blood vessels and few lymphocytes and
macrophages. Some specimens presented moderate
inflammatory infiltrate, especially those in which it was still
possible to visualize the graft resorption process. Regarding
the quality, the newly formed bone structure of this group
was more immature, as demonstrated by the disorganization
of its bone lamellae and osteocytes. Although the bone
grafts remained vital, part of the osteocyte lacunas were
empty (Figure 6).
Histometric Results
The amount of newly formed bone is presented in Table
1.
Quantitatively, the results of new bone formation in tibia
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FIGURE 1- Group CG10: Bone fragments corresponding to
the grafts (BG) and numerous osteoblasts (arrows) close
to the newly formed bone tissue margins and the graft
fragments. HE. (Original magnification x160)
FIGURE 2- Group DG10: Devitalized bone graft (GB)
characterized by the absence of osteocytes inside the
mineralized material. Osteoblasts around the newly formed
bone and the graft, showing new bone formation activity.
HE. (Original magnification x160)
FIGURE 3- Group CC30: Higher amount of newly formed
bone closing the surgical site margins and decreasing as
closer it got to the defect central area. Masson’s Trichrome
(Original magnification x63)
FIGURE 4- Group CG30: Total closing of the defect by well
formed bone. Bone graft is totally incorporated to the newly
formed bone area. Masson’s Trichrome (Original
magnification x63)
FIGURE 5- Group DC30: Surgical defect repaired by
disorganized bone tissue with remnant of wide
intratrabecular spaces and cortical thickness decrease at
the defect central area. Masson’s Trichrome (Original
magnification x63)
FIGURE 6- Group DG30: Bone grafts incorporated to the
newly formed bone by thin bone trabeculae, with wide
intratrabecular spaces and disorganized osteocyte
lamellae. Masson’s Trichrome (Original magnification x63)
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Group 10 days 30 days
n Mean (%) n Mean (%)
CC 9 42.4 ± 7 10 71.3 ± 7
CG 9 52.5 ± 9 10 75.9 ± 11
DC 10 43.8 ± 4 10 50.7 ± 13
DG 10 52.0 ± 7 10 68.9 ± 12
TABLE 1- Percentage of newly formed bone per group
cortical in the grafted surgical defects at the 10th
postoperative day differed significantly (p<0.05) from those
observed in the surgical defects that received the blood
clot. In the control group, the percentage of bone area formed
in the defects that received graft and blood clot was 52.5 ±
9% and 42.4 ± 7%, respectively. At 30 days, although there
was a larger newly formed bone area in the grafted defects
(75.9 ± 11%) compared to the defects filled with blood clot
(71.3 ± 7%), this difference was not significant (p>0.05).
Similar results were observed in the diabetic group at 10
and 30 postoperative days, which presented significantly
larger bone area in the grafted defects (52.0 ± 7%; p<0.05
and 68.9 ± 12 %, respectively; p<0.01) compared to the
defects filled with blood clot (43.8 ± 4% and 50.7 ± 13%,
respectively).
In the defects that received blood clot, an unexpected
inversion of results occurred at the 10-day period (43.8 ±
4%), since the diabetic group presented a slightly more
accentuated new bone formation than that observed in the
control group (42.4 ± 7%), though without statistical
significance. However, at the 30-day period, higher bone
repair was observed in the control group (71.3 ± 7%)
compared to the diabetic group (50.7 ± 13%) (Table 1).
Regarding the surgical defects filled with autogenous bone
graft, the bone repair in diabetic rats occurred later than in
the control animals in both evaluated periods (DG10 = 52.0
± 7%< CG10 52.5 ± 9% and DG30 = 68.9 ± 12 < CG30 = 75.9 ±
11%) (Table 1).
DISCUSSION
Diabetes mellitus is a well known disease that weakens
the patient’s general metabolism7 and changes the cellular
and humoral immunity9,16,17, increasing the risk of infections
when the organism is submitted to surgical procedures1,14,15.
Moreover, the delay in cell proliferation12, the decrease of
collagen metabolism5 and all other granulation tissue
components, such as glycoproteins and
mucopolysaccharides4,6, are direct consequences of the
disease that severely affects the tissue repair process.
In the experimental model used in this study, the animals
developed streptozotocin-induced diabetes. This substance
produces irreversible effects on the pancreas and generates,
after induction of diabetes, irreversible organic metabolic
conditions similar to those observed in humans. The diabetic
status occurs in the first hour after drug administration, but
the clinical signs of this new systemic condition appear
only 24 h after streptozotocin injection3. Determination of
the glycemic levels and surgical procedures were performed
5 and 7 days after induction of diabetes, respectively, in
order to allow adaptation of the animals to the new metabolic
condition and thus minimize the possibility of variations in
their physiological behavior.
The bone repair process is particularly affected in
diabetic individuals because the hyperglycemic status leads
to an increase of bone resorption and a decrease of bone
turnover8. In addition, there is a decrease in osteoblastic
differentiation10 and a delay in the revascularization
process2,11, which, according to Santana, et al.13 reduces by
approximately 60% the bone repair ability compared to a
healthy organism.
Comparing the sub-groups “blood clot” and
“autogenous bone graft” within the control and diabetic
group, the treatment of bone wounds with autografts
promoted significantly better results than filling of the defects
with blood clot at both periods (10 and 30 days).
Although similar results were found between control
and diabetic groups after histometric analysis of the bone
area, the results were qualitatively very distinct. The
presence of intratrabecular spaces with connective tissue
still in organization was the main characteristic of the
diabetic wounds at 10 days. The inflammatory infiltrate also
seemed more intense when compared to the control group
in the initial repair periods. Collagen fiber deposition is less
intense and less organized in the diabetic organism,
especially in the earlier repair periods.
Bone graft vitality also seemed to be reduced in the
diabetic group because, in addition to having thinner and
disorganized trabeculae, there was an intense osteoclastic
activity, especially in the inner margins of the bone grafts.
Empty osteocyte lacunas were found in some experimental
diabetic animals (Figure 2).
During the analysis of the groups that received only
blood clot in the defects, it was verified an unexpected
inversion of the results from the 10-day period, as the new
bone formation that occurred in the diabetic group was
slightly more accentuated when compared to the control
group. However, it is important to emphasize that the quality
of the newly formed bone in the diabetic-blood clot group
at 10 days, as well as the bone constituents present in the
intratrabecular spaces, such as inflammatory infiltrate, newly
formed vessels and collagen fibers, showed slightly worse
characteristics. At the 30-day period, the results followed
expected patterns, with a prevalence of bone formation in
the control group when compared to the diabetic group.
Although complete repair of the surgical defects by newly
formed bone tissue at 30 days was observed in all specimens,
the presence of intratrabecular spaces was more persistent
in the diabetic group, with a larger number of blood vessels
and discreetly greater inflammatory infiltrate, which resulted
in a more accentuated qualitative impairment of the repair
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process.
Incorporation of bone fragments was also observed in
both groups and periods. However, in spite of the smaller
inflammatory infiltrate and the larger number of osteoblasts
and collagen fibers in the intratrabecular spaces of the
control group, the diabetic organism response to bone grafts
was considered as very satisfactory, given that the repair
process in diabetics is recognizably impaired2.
Although similarities were found between the groups at
the earlier stages of the alveolar repair, it is likely that great
part of the changes in tissue repair in the diabetic animals
are due to the delays in the proliferative stage of the repair
process2,12. It is likely that such alterations led to a qualitative
bone repair delay, although the greatest discrepancies
between the groups were more evident at 30 postoperative
days.
CONCLUSIONS
Based on the results of the present study, it may be
concluded that: 1. The bone repair of surgical defects filled
with bone grafts occurred earlier than that of surgical defects
filled with blood cot in both control and diabetic groups; 2.
Regarding surgical defects filled with blood clot, the repair
process in the control group was qualitatively better than
the repair in diabetic group in both evaluated periods, with
significant difference at 30 days period; 3. Regarding the
surgical defects filled with bone grafts, the control group
showed better bone repair than the diabetic group, though
without statistical significance.
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